Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver.

[1]  R. Levine,et al.  Digital Quantification Is More Precise than Traditional Semiquantitation of Hepatic Steatosis: Correlation with Fibrosis in 220 Treatment-Naïve Patients with Chronic Hepatitis C , 2010, Digestive Diseases and Sciences.

[2]  L. Bujanda,et al.  Biochemical determination of lipid content in hepatic steatosis by the Soxtec method. , 2010, World journal of gastroenterology.

[3]  M. Fiorentino,et al.  Predictive value of frozen‐section analysis in the histological assessment of steatosis before liver transplantation , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  K. Washington,et al.  Assessment of Hepatic Steatosis by Expert Pathologists: The End of a Gold Standard , 2009, Annals of surgery.

[5]  F. Schick,et al.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.

[6]  Bruno Turlin,et al.  Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[7]  O. Cummings,et al.  Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. , 2008, Journal of hepatology.

[8]  O. Cummings,et al.  Relationship Among Histologic, Radiologic, and Biochemical Assessments of Hepatic Steatosis: A Study of Human Liver Samples , 2007, Journal of clinical gastroenterology.

[9]  V. Rodríguez-Sureda,et al.  A procedure for measuring triacylglyceride and cholesterol content using a small amount of tissue. , 2005, Analytical biochemistry.

[10]  Lennart Bodin,et al.  Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting , 2005, Modern Pathology.

[11]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[12]  Scott L Nyberg,et al.  Assessment of donor liver steatosis: pathologist or automated software? , 2004, Human pathology.

[13]  S. Ukabam,et al.  Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C , 2001, Journal of clinical pathology.

[14]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[15]  J. Goldblum,et al.  Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[16]  D. Pessayre,et al.  Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. , 1997, Journal of hepatology.

[17]  K. Batts,et al.  Use of fatty donor liver is associated with diminished early patient and graft survival. , 1996, Transplantation.

[18]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.